N04.4 Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis

Name of the Condition

• Nephrotic Syndrome with Diffuse Endocapillary Proliferative Glomerulonephritis
• ICD-10 Code: N04.4

Summary

Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis is a kidney disorder characterized by significant protein loss in the urine (proteinuria), low blood protein levels (hypoalbuminemia), high cholesterol (hyperlipidemia), and swelling (edema). The condition involves diffuse proliferation of cells within the glomeruli's capillary loops, impairing filtration and leading to protein leakage. It is a specific histologic subtype of nephrotic syndrome, often associated with inflammatory or immune-mediated processes.

Causes

The condition typically arises from immune-mediated or inflammatory processes affecting the glomeruli. Primary causes may include certain glomerulonephritides, while secondary causes can involve infections (e.g., post-streptococcal), systemic diseases (e.g., lupus), or medications. In some cases, the underlying trigger remains unidentified, though the diffuse endocapillary proliferation suggests an active inflammatory response.

Risk Factors

• Underlying autoimmune or inflammatory conditions
• Prior infections (e.g., bacterial or viral)
• Exposure to nephrotoxic medications
• Genetic predisposition to glomerular diseases
• Uncontrolled systemic conditions (e.g., hypertension, diabetes)

Symptoms

• Severe swelling (edema), particularly in the legs, ankles, or around the eyes
• Foamy or frothy urine due to excess protein
• Unexplained weight gain from fluid retention
• Fatigue and loss of appetite
• High cholesterol levels

Diagnosis

Diagnosis involves urine tests to detect proteinuria, blood tests to assess kidney function and protein levels, and a kidney biopsy to confirm diffuse endocapillary proliferative changes. Additional tests may evaluate for underlying causes, such as serologic markers for infections or autoimmune diseases. Imaging studies are typically not required unless complications are suspected.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying cause. This may include medications to reduce proteinuria (e.g., corticosteroids, immunosuppressants), blood pressure control, and lipid management. Dietary modifications, such as reduced salt and protein intake, may also be recommended. In severe cases, dialysis or kidney transplantation may be necessary.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and response to treatment. Some patients achieve remission with therapy, while others may experience progressive kidney damage. Regular follow-up with kidney function monitoring, blood pressure checks, and medication adjustments is essential. Long-term management may be required to prevent complications.

Complications

• Progressive kidney failure requiring dialysis or transplantation
• Blood clots (thromboembolism) due to protein loss
• Infections from immunosuppressive therapy
• Malnutrition or vitamin deficiencies
• Cardiovascular disease from prolonged hyperlipidemia

Lifestyle & Prevention

• Maintain a balanced diet with controlled salt and protein intake
• Manage underlying conditions (e.g., diabetes, hypertension)
• Avoid nephrotoxic medications unless medically necessary
• Stay hydrated and monitor fluid status
• Engage in regular physical activity as tolerated

When to Seek Professional Help

Seek immediate medical attention for severe swelling, sudden weight gain, reduced urine output, or signs of infection (e.g., fever, chills). Contact a healthcare provider for persistent fatigue, unexplained weight changes, or worsening symptoms. Regular follow-up is critical for monitoring kidney function and treatment response.

Tips for Medical Coders

Document the presence of diffuse endocapillary proliferative glomerulonephritis to support the N04.4 code. Include details on biopsy findings, underlying causes (if known), and clinical manifestations (e.g., proteinuria, edema) to ensure accurate coding. Verify that the diagnosis aligns with the histologic subtype and exclude other nephrotic syndrome codes unless specified.